[PDF] Unravelling the causes of inner ear disease
MF Pereira - 2017
… uma apresentação de painel no 5th International Multidisciplinary Vestibular Disorder Course
& Workshop (Granada, Espanha) denominada "Pro-inflamatory cytokines in Vestibular Migraine
and Meniere's Disease" Page 3 … FMD Familial Meniere's Disease …
& Workshop (Granada, Espanha) denominada "Pro-inflamatory cytokines in Vestibular Migraine
and Meniere's Disease" Page 3 … FMD Familial Meniere's Disease …
[PDF] Hipoacusia infantil: un estudio retrospectivo de prevalencia, detección precoz y actuación en el complejo hospitalario y universitario de Albacete
L Roque Taveras - 2018
… Pueden ser debidas a (1,5): o Meningitis, encefalitis o Sarampión o Otitis media crónica o
Laberintitis o Ototoxicidad o Enfermedad de Meniere o Traumatismo craneoencefálico o
Enfermedades autoinmunes o Anemia de células falciformes o Otras …
Laberintitis o Ototoxicidad o Enfermedad de Meniere o Traumatismo craneoencefálico o
Enfermedades autoinmunes o Anemia de células falciformes o Otras …
Effects of Common Ear Drops on Tympanic Membrane Healing in Rats
CO Dirain, B Kosko, PJ Antonelli - Otolaryngology–Head and Neck Surgery, 2018
Objective Ciprofloxacin + dexamethasone ear drops have been associated with higher rates
of tympanic membrane perforations than ofloxacin. This was thought to b...
of tympanic membrane perforations than ofloxacin. This was thought to b...
[HTML] Prevalence, aetiologies and prognosis of the symptom dizziness in primary care–a systematic review
S Bösner, S Schwarm, P Grevenrath, L Schmidt… - BMC Family Practice, 2018
… Peripheral vestibular. 14.4% [11.2; 18.2]. 34.0% [21.6; 48.9]. BPPV. 8.0% [2.6; 20.1]. Vestibular
neuritis. 24.0% [13.5; 38.5]. Morbus Meniere. –. 2.0% [0.1-12.0]. Cardiovascular. 56.8% [51.9;
61.6] a. 48.0% [33.9; 62.4]. Neurological central. 2.9% [1.6; 5.1] b. 10.0% [3.7; 22.6] …
neuritis. 24.0% [13.5; 38.5]. Morbus Meniere. –. 2.0% [0.1-12.0]. Cardiovascular. 56.8% [51.9;
61.6] a. 48.0% [33.9; 62.4]. Neurological central. 2.9% [1.6; 5.1] b. 10.0% [3.7; 22.6] …
1: Pérez-Garrigues H, Yaya R, López-Arlandis J, Burguera JA, Morera C, Alamar A, Grau E.[Oculographic findings in the Arnold-Chiari malformation type I]. An …
G Piera, OIA An
… PubMed PMID: 8214446. 14: Perez-Garrigues H, Lopez-Escamez JA, Perez P, Sanz R, Orts M,
Marco J, Barona R, Tapia MC, Aran I, Cenjor C, Perez N, Morera C, Ramirez R. Time course
of episodes of definitive vertigo in Meniere's disease. Arch Otolaryngol Head Neck Surg …
Marco J, Barona R, Tapia MC, Aran I, Cenjor C, Perez N, Morera C, Ramirez R. Time course
of episodes of definitive vertigo in Meniere's disease. Arch Otolaryngol Head Neck Surg …
[PDF] Clinical Decision-Making for a Patient with Dizziness, Ruling out Vertebrobasilar Insufficiency: A Case Study
C Medinger - 2017
… Arch Phys Med Rehabil. 1996 Sep; 77(9):874-82. 12. Knox GW, McPherson A. Meniere's disease:
differential diagnosis and treatment. Am Fam Physician. 1997 Mar;55(4):1185-90. 13. Landel
R. Use of traction to treat cervicogenic dizziness: a case study. J Physiother …
differential diagnosis and treatment. Am Fam Physician. 1997 Mar;55(4):1185-90. 13. Landel
R. Use of traction to treat cervicogenic dizziness: a case study. J Physiother …
HYBRID OLIGONUCLEOTIDES AND USES THEREOF
F Ozsolak - US Patent App. 15/550,108, 2018
Provided herein are hybrid oligonucleotides comprising a region that
promotes cleavage of a nucleic acid and a region that protects a nucleic
acid from exonuclease activity. Such hybrid oligonucleotid.
promotes cleavage of a nucleic acid and a region that protects a nucleic
acid from exonuclease activity. Such hybrid oligonucleotid.
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου